JP2021531038A5 - - Google Patents

Download PDF

Info

Publication number
JP2021531038A5
JP2021531038A5 JP2021523576A JP2021523576A JP2021531038A5 JP 2021531038 A5 JP2021531038 A5 JP 2021531038A5 JP 2021523576 A JP2021523576 A JP 2021523576A JP 2021523576 A JP2021523576 A JP 2021523576A JP 2021531038 A5 JP2021531038 A5 JP 2021531038A5
Authority
JP
Japan
Prior art keywords
protein
protein construct
liquid
patient
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021523576A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020014588A5 (https=
JP2021531038A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/041564 external-priority patent/WO2020014588A1/en
Publication of JP2021531038A publication Critical patent/JP2021531038A/ja
Publication of JPWO2020014588A5 publication Critical patent/JPWO2020014588A5/ja
Publication of JP2021531038A5 publication Critical patent/JP2021531038A5/ja
Pending legal-status Critical Current

Links

JP2021523576A 2018-07-13 2019-07-12 ストレス顆粒集合を調節するためのシステム及び方法 Pending JP2021531038A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862697691P 2018-07-13 2018-07-13
US62/697,691 2018-07-13
US201862719751P 2018-08-20 2018-08-20
US62/719,751 2018-08-20
PCT/US2019/041564 WO2020014588A1 (en) 2018-07-13 2019-07-12 System and method for modulating stress granule assembly

Publications (3)

Publication Number Publication Date
JP2021531038A JP2021531038A (ja) 2021-11-18
JPWO2020014588A5 JPWO2020014588A5 (https=) 2022-12-06
JP2021531038A5 true JP2021531038A5 (https=) 2022-12-06

Family

ID=69142650

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021523576A Pending JP2021531038A (ja) 2018-07-13 2019-07-12 ストレス顆粒集合を調節するためのシステム及び方法

Country Status (5)

Country Link
US (1) US12195768B2 (https=)
EP (1) EP3820494A4 (https=)
JP (1) JP2021531038A (https=)
CN (1) CN112423781A (https=)
WO (1) WO2020014588A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3820494A4 (en) 2018-07-13 2022-07-13 The Trustees of Princeton University System and method for modulating stress granule assembly
CN113135987B (zh) * 2021-06-10 2022-07-12 浙江师范大学 一类来源于Caprin1的活性肽及其应用
CN113214361B (zh) * 2021-06-10 2022-06-10 浙江师范大学 一类包含fgdf基序的应激颗粒抑制剂及其应用
WO2023174838A1 (en) * 2022-03-14 2023-09-21 F. Hoffmann-La Roche Ag Modulators of the g3bp2-tau interaction for the treatment of tau associated diseases
EP4269424A1 (en) * 2022-04-25 2023-11-01 Københavns Universitet Novel antiviral compounds and use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR721101A0 (en) 2001-08-23 2001-09-13 University Of Queensland, The Nucleic acid and polypeptide linked to breast cancer
JPWO2007132555A1 (ja) * 2006-05-11 2009-09-24 国立大学法人 東京大学 細胞膜透過性ペプチドと細胞内におけるその使用
EP2804598B1 (en) * 2012-01-17 2019-05-15 Kyoto University Prophylactic and therapeutic drug for amyotrophic lateral sclerosis and method of screening therefor
JP6340366B2 (ja) * 2012-07-31 2018-06-06 イェダ リサーチ アンド デベロップメント カンパニー リミテッド 運動ニューロン疾患を診断および処置する方法
GB201318954D0 (en) * 2013-10-28 2013-12-11 Cupid Peptide Company Ltd Cell transport
JP2019500899A (ja) * 2015-11-23 2019-01-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア CRISPR/Cas9の核送達を通じた細胞RNAの追跡と操作
US20190085034A1 (en) 2016-03-16 2019-03-21 Tarveda Therapeutics, Inc. Antibody mimic conjugates and particles
US10668128B2 (en) * 2017-02-15 2020-06-02 University Of South Carolina Targeting G3BP proteins to accelerate nerve regeneration
MX2019013835A (es) * 2017-05-24 2020-07-14 Orphazyme As Inductores de proteinas de choque termico y trastornos frontotemporales.
US10526380B2 (en) * 2017-10-26 2020-01-07 St. Jude Children's Research Hospital Fusion protein and nucleic acid molecule for light-dependent stress granule assembly
EP3820494A4 (en) 2018-07-13 2022-07-13 The Trustees of Princeton University System and method for modulating stress granule assembly

Similar Documents

Publication Publication Date Title
JP2021531038A5 (https=)
Wagner et al. Signaling mechanisms and pharmacological modulators governing diverse aquaporin functions in human health and disease
Madabhushi The roles of DNA topoisomerase IIβ in transcription
Bonaparte et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus
Hovanessian Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin
JP2014515602A5 (https=)
CN112040988A (zh) 修饰的aav衣壳多肽用于治疗肌肉疾病
Rai et al. Genetic delivery and gene therapy in pulmonary hypertension
JP2013541335A5 (https=)
RU2012101485A (ru) Биспецифические четырехвалентные антигенсвязывающие белки
BR112021003410A2 (pt) anticorpos de domínio único anti-bcma, grupo de genes dos ditos anticorpos, polipeptídeo, vetor de expressão, célula hospedeira, receptor de antígeno quimérico, célula t modificada pelo mesmo, composição farmacêutica e usos dos ditos anticorpos
JP2008530138A5 (https=)
IL187321A (en) Host cell specific binding molecules encoding monoclonal antibodies capable of neutralizing viruses, pharmaceutical compositions comprising them and uses thereof in the preparation of medicaments
RU2014132108A (ru) Slit-robo сигналинг для диагностики и лечения заболевания почек
Pei et al. HSP70 ameliorates septic lung injury via inhibition of apoptosis by interacting with KANK2
CN104395475B (zh) 基于jcv-病毒样颗粒的新型药物递送系统
CN104411825B (zh) 骨膜蛋白适配体及包含其的抗癌组合物
De Genst et al. Blocking phospholamban with VHH intrabodies enhances contractility and relaxation in heart failure
JP2021181450A (ja) 細胞内抗原に対して向けられた単一ドメイン抗体
JP2010507666A5 (https=)
CN108220336A (zh) 基于细胞内NF-κB活性激活效应基因在NF-κB过度活化细胞内的基因表达及应用
Janecki et al. Poly (C)-binding protein 2 regulates the p53 expression via interactions with the 5′-Terminal region of p53 mRNA
Odeh et al. Anti-fibrotic, muscle-promoting antibody-drug conjugates for the improvement and treatment of DMD
Rodriguez et al. Tau gene deletion does not influence axonal regeneration and retinal neuron survival in the injured mouse visual system
Manzel et al. Regulation of bacteria-induced intercellular adhesion molecule-1 by CCAAT/enhancer binding proteins